Status:

RECRUITING

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Lead Sponsor:

Vincent Tay Khwee Soon

Collaborating Sponsors:

Changi General Hospital

Singapore General Hospital

Conditions:

Alzheimer Disease

Dementia Alzheimer Type

Eligibility:

All Genders

50-80 years

Phase:

NA

Brief Summary

Alzheimer's disease (AD), one of the most common causes of dementia in Singapore and the developed world, is a neurodegenerative disorder with high socioeconomic impact. Accumulation of neurotoxic pro...

Eligibility Criteria

Inclusion

  • Diagnosis of mild-moderate Alzheimer's disease (based on NIA-AA criteria);
  • Mini-Mental State Examination (MMSE) score 12-22;
  • Both participants and caregiver are able to understand English or Mandarin
  • Ability to provide informed consent or have a legally authorised representative to provide informed consent;
  • Good family support for post-treatment care and rehabilitation;
  • Fit for general anaesthesia/deep sedation and surgery (ASA 1-2; excluding the diagnosis of Alzheimer's Disease).

Exclusion

  • Severe, confluent vascular burden on neuroimaging (eg. Fazeka 3);
  • Cognitive decline due to prior infection or autoimmune diseases;
  • History of major cerebrovascular events or significant cardiovascular diseases;
  • Inability to have the head turned passively by at least 40 degrees;
  • Previous neck lymph node surgery or irradiation;
  • Active infection or malignancy;
  • Any contraindications to surgery or lumbar puncture
  • Any contraindication to MRI/PET scan (eg. metallic implant that are not MRI-safe, known radiotracer allergy)
  • Experimental Alzheimer's Disease treatment within the past 6 months. • Current use of monoclonal antibodies treatment (eg. lecanemab/donanemab)

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2030

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06965062

Start Date

April 1 2025

End Date

March 31 2030

Last Update

May 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Changi General Hospital

Singapore, Singapore